RecruitingNot ApplicableNCT06384755

Honest Open Proud for Psychotic and Bipolar Disorder in Norway

Evaluation of a Norwegian Adaptation of the Honest Open Proud Program for Adults With Psychotic and Bipolar Disorders in an Outpatient Setting

Sponsor

Oslo University Hospital

Enrollment

40 participants

Start Date

Apr 20, 2024

Study Type

INTERVENTIONAL

Conditions

Psychotic Disorders Bipolar Disorder Disclosure

Summary

The purpose of this pilot study is to evaluate the feasibility, acceptability and efficacy of a Norwegian adaptation of the group-based intervention 'Honest Open Proud' among adults with psychotic and bipolar disorders in an outpatient setting.

Eligibility

Min Age: 18 YearsMax Age: 65 Years

Plain Language Summary

Simplified for easier understanding

This Norwegian study is testing a program called 'Honest Open Proud' — a group-based intervention designed to help people with psychosis or bipolar disorder manage the stigma of mental illness and make thoughtful decisions about who to tell about their condition. **You may be eligible if...** - You are between 18 and 65 years old - You have a diagnosis of psychosis or bipolar disorder - You speak Norwegian fluently - You experience difficulties related to the stigma of mental illness and decisions about disclosure **You may NOT be eligible if...** - You have an intellectual disability - You have an organic brain disorder (caused by a physical brain condition) Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORALHonest Open Proud program

The HOP program involves peer facilitated sessions, in which different stigma and disclosure related topics are introduced to the group, relevant tasks are completed individually, followed by group or two-and-two discussions related to the following topics: week 1 = pros and cons with disclosure, week 2 = different ways of disclosing, week 3 = formulating individual decisions of disclosure, week 6 = evaluating disclosure or non-disclosure in practice.

Locations(2)

Nydalen DPS, Division of Mental Health and Addiction, Oslo University Hospital

Oslo, Norway

Søndre Oslo DPS, Division of Mental Health and Addiction, Oslo University Hospital

Oslo, Norway

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06384755

Related Trials

A Study to Evaluate the Effectiveness of Valbenazine in Adult Participants With Tardive Dyskinesia (TD) Who Remain Symptomatic While Receiving or After Stopping a Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor

NCT0710511121 locations

The Impact of AMPA Receptor Blockade on Ketamine's Anti-Suicidal Effects

NCT057860661 location

AI-Driven Consent Simplification Study

NCT073035171 location

A Randomized Study of Azetukalner Versus Placebo in Depressive Episodes Associated With Bipolar I or II Disorder (Bipolar Depression)

NCT0717251628 locations

NIMH Rhythms and Blues Study: A Prospective Natural History Study of Motor Activity, Mood States, and Bipolar Disorder

NCT056697031 location